Worse Outcomes in HLA-B27+ JIA
Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.
https://t.co/VEKqHvO1qw https://t.co/49y0JQL0Gr
Links:
Worse Outcomes in HLA-B27+ JIA | RheumNow
https://buff.ly/8r1rpPY
Mar-28-2025


